The US will miss its 5% smoking prevalence target by 2030, known as Healthy People 2030, without hiking taxes on cigarettes, finds an analysis published online in the journal Tobacco Control. Only 5 states and the District of Columbia (DC)…
Read More
U.S. pediatricians, psychiatrists declare ’emergency’ in child mental health
(HealthDay)—Fear, grief, uncertainty and isolation during the pandemic have triggered a national state of emergency in the mental health of America’s youth, leading child health care groups warned Tuesday. Youngsters already faced significant mental health challenges, and the pandemic has…
Read More
Half of U.S. parents may not vaccinate their youngest child against COVID-19
Even as the delta variant of COVID-19 sweeps the globe, leaving those who remain unvaccinated vulnerable, vaccination among adults and teenagers in the United States is stalling, giving rise to concerns over whether parents will vaccinate their young children once…
Read More
U.S. public health experts call for 'urgent action' to assess Olympics
Public health experts call for athletes to wear proximity sensors at Tokyo Olympics if it is to go ahead alongside list of ‘urgent’ COVID measures Four health experts from the US published a letter this week calling for a revision…
Read More
Many U.S. colleges will mandate vaccines on campus next fall
(HealthDay)—More than 100 American colleges will require that students get COVID-19 vaccines if they want to be on campus in the fall, a new survey shows. More than 660,000 cases have been linked to universities since the start of the…
Read More
U.S. FDA Approves ALK’s Ragwitek (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use as Immunotherapy for Children and Adolescents With Short Ragweed Pollen-Induced Allergic Rhinitis With or Without Conjunctivitis
ROUND ROCK, Texas, April 19, 2021 /PRNewswire/ — ALK (ALKB: DC / OMX: ALK B / AKABY / AKBLF), a global, research-driven pharmaceutical company that focuses on the diagnosis and treatment of allergies, announced that the U.S. Food and Drug…
Read More
AI tool can spot Type 2 diabetes trends in the U.S.
A new University at Buffalo study reports on the advantages of using artificial intelligence to better understand Type 2 diabetes across the United States. The study describes how machine learning—a subset of AI that involves computers acting intelligently without being…
Read More
Domestic air travel does not appear to have been an important vector for the spread of COVID-19 in the U.S.
Fear of flying and catching COVID-19 led to a massive decline in air travel in 2020. But an interesting question emerges: How much did air travel contribute to the early, and uneven, spread of COVID-19 in the U.S.? In a…
Read More
One year into pandemic, Biden promises vaccines for all U.S. adults by May 1
During a speech reassuring Americans that the pandemic could be nearing its end in this country, President Joe Biden on Thursday promised that all U.S. adults will be eligible for a coronavirus vaccine by May 1. His remarks came on…
Read More
U.S. FDA Expands Approval of Pfizer’s Lorbrena as First-Line Treatment for ALK-Positive Metastatic Lung Cancer
NEW YORK–(BUSINESS WIRE) March 03, 2021 — The U.S. Food and Drug Administration (FDA) approved Pfizer Inc.’s (NYSE: PFE) supplemental New Drug Application (sNDA) for Lorbrena® (lorlatinib), expanding the indication to include first-line treatment of people with anaplastic lymphoma kinase…
Read More